CRYSTAL CARMICHEAL: Open Payments
NPI 1629403423 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 13 payments from 5 companies in 2025. Trend: 2023 $270 · 2024 $326 · 2025 $704
Food & beverage: $356Education: $348
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 5 | $311 |
| Astellas Pharma US Inc | 5 | $308 |
| Janssen Biotech, Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Teleflex LLC | 1 | $25 |
Products named: Jakafi, Cresemba, NIKTIMVO, DARZALEX, LIVTENCITY, MONJUVI, ARROW.
Industry payments across TX — which companies pay providers there.
